Pacs Group Inc Revenue Growth Rates (PACS), Current and Historic Growth - CSIMarket
CSIMarket
 


Pacs Group Inc   (NYSE: PACS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

PACS's Revenue Growth by Quarter and Year

Pacs Group Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PACS/growth
https://api.csimarket.com/api/v1/companies/PACS/fundamentals
https://api.csimarket.com/api/v1/companies/PACS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
PACS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1,498.58
2nd Quarter June 1,428.00
1st Quarter March 1,420.49
FY 4,347.07





PACS Revenue third quarter 2026 Y/Y Growth Comment
Pacs Group Inc reported Revenue increase of 11.45% year on year in the third quarter 2026, to $ 1,498.58 millions, this is lower than Pacs Group Inc 's recent average Revenue improvement of 26.7%.

Looking into third quarter 2026 results within Healthcare Facilities industry 11 other companies have achieved higher Revenue growth. While Pacs Group Inc ' s Revenue growth of 11.45% ranks overall at the positon no. 1823 in the third quarter 2026.




PACS Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 11.45 %
2nd Quarter June 9.07 %
1st Quarter March 11.22 %
FY   -

Financial Statements
Pacs Group Inc 's third quarter 2026 Revenue $ 1,498.58 millions PACS's Income Statement
Pacs Group Inc 's third quarter 2025 Revenue $ 1,344.57 millions Quarterly PACS's Income Statement


PACS Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 4.94 %
2nd Quarter June 0.53 %
1st Quarter March 4.6 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #284
Overall #1823

Revenue Y/Y Growth Statistics
High Average Low
41.57 % 26.7 % 9.07 %
(Jun 30 2025)   (Jun 30 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #12
Healthcare Sector #284
Overall #1823
Revenue Y/Y Growth Statistics
High Average Low
41.57 % 26.7 % 9.07 %
(Jun 30 2025)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Pacs Group Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
17.69 % 5.63 % 0.53 %
(Dec 31 2024)  


PACS's III. Quarter Q/Q Revenue Comment
Pacs Group Inc achieved in the III. Quarter 2026 below company average Revenue growth of 4.94% quarter on quarter, to $ 1,498.58 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 2.7% in the III. Quarter a year ago.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Pacs Group Inc 's Revenue growth quarter on quarter, overall rank is 1663.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #223
Overall #1663
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #19
Healthcare Sector #223
Overall #1663
Revenue Q/Q Growth Statistics
High Average Low
17.69 % 5.63 % 0.53 %
(Dec 31 2024)  


PACS's III. Quarter Q/Q Revenue Comment
Pacs Group Inc achieved in the III. Quarter 2026 below company average Revenue growth of 4.94% quarter on quarter, to $ 1,498.58 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 2.7% in the III. Quarter a year ago.

Within Healthcare Facilities industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Pacs Group Inc 's Revenue growth quarter on quarter, overall rank is 1663.


Pacs Group Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)
12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 5,705.05
Y / Y Revenue Growth (TTM) 11.02 %
Year on Year Revenue Growth Overall Ranking # 445
Seqeuential Revenue Change (TTM) 2.77 %
Seq. Revenue Growth (TTM) Overall Ranking # 1685


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Pacs Group Inc 's cumulative twelve months Revenue were $ 5,705 millions, company would post below average annual Revenue growth of 2.77% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Pacs Group Inc 's Revenue growth from the 1428% growth in Jun 30 2026.

In the Healthcare sector 107 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 445, from total ranking in previous quarter at 685.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 15
Healthcare Sector # 108
Overall # 445

Revenue TTM Y/Y Growth Statistics
High Average Low
37.81 %
29.61 %
15.15 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 270
S&P 500 # 1685
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Sep 30 2026 period, Pacs Group Inc 's cumulative twelve months Revenue were $ 5,705 millions, company would post below average annual Revenue growth of 15.15% year on year, if the fiscal year would end at Sep 30 2026.
A slow-down in the Pacs Group Inc 's Revenue growth from the 1428% growth in Jun 30 2026.

In the Healthcare sector 107 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 445, from total ranking in previous quarter at 685.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 15
Healthcare Sector # 108
Overall # 445

Revenue TTM Y/Y Growth Statistics
High Average Low
37.81 %
29.61 %
15.15 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 15
Sector # 270
S&P 500 # 1685




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PACS's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Alpha Pro Tech Ltd 19.73%$ 19.729 millions
Insulet Corporation19.21%$ 19.213 millions
Abcellera Biologics Inc 18.81%$ 18.805 millions
Schrodinger Inc 18.72%$ 18.715 millions
Procept Biorobotics Corporation18.41%$ 18.414 millions
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions
Outset Medical Inc 17.51%$ 17.510 millions
Alnylam Pharmaceuticals Inc 16.74%$ 16.738 millions
IMPACT BIOMEDICAL INC.16.67%$ 16.667 millions
Rigel Pharmaceuticals Inc16.45%$ 16.452 millions
Si bone inc 16.42%$ 16.424 millions
Ars Pharmaceuticals Inc 16.03%$ 16.027 millions
Atricure Inc 15.84%$ 15.839 millions
Ardelyx inc 15.70%$ 15.704 millions
Novocure Limited15.67%$ 15.666 millions
Penumbra Inc15.64%$ 15.636 millions
Orasure Technologies Inc15.45%$ 15.445 millions
Electromed Inc 15.34%$ 15.342 millions
Irhythm Holdings Inc 15.34%$ 15.339 millions
P3 Health Partners Inc 14.80%$ 14.798 millions
Msa Safety Inc14.72%$ 14.716 millions
Ensign Group Inc14.47%$ 14.471 millions
Abbott Laboratories14.46%$ 14.460 millions
Electrocore Inc 14.40%$ 14.404 millions
Allogene Therapeutics Inc 14.29%$ 14.286 millions
Tandem Diabetes Care Inc 14.26%$ 14.257 millions
Iradimed Corporation14.15%$ 14.154 millions
Apyx Medical Corp14.09%$ 14.093 millions
Incyte Corporation14.00%$ 13.999 millions
Aurinia Pharmaceuticals Inc 13.93%$ 13.926 millions


About Pacs Group Inc Revenue Growth Rates (PACS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Pacs Group Inc (CIK 2001184).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0002001184-26-000040
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Pacs Group Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.